Media coverage
49
Media coverage
Title PreciseDx Announces Publication in Breast Cancer Research; Validates Its AI-Enabled Platform that Predicts Early-Stage Breast Cancer Recurrence Better than Current Industry Standard Media name/outlet PR Newswire Country/Territory United States Date 19/01/23 URL ct.moreover.com/?a=49787588610&p=1gw&v=1&x=0zcXlX3Wjorthj9-czYrMQ Persons Michael Donovan Title PreciseDx Announces Publication in Breast Cancer Research; Validates Its AI-Enabled Platform that Predicts Early-Stage Breast Cancer Recurrence Better than Current Industry Standard Media name/outlet Street Insider Country/Territory United States Date 19/01/23 URL ct.moreover.com/?a=49787355472&p=1gw&v=1&x=DOrOygxaU6AVzuVHIjqwag Persons Michael Donovan Title PreciseDx Announces Publication in Breast Cancer Research; Validates Its AI-Enabled Platform that Predicts Early-Stage Breast Cancer Recurrence Better than Current Industry Standard Media name/outlet BioSpace Country/Territory United States Date 19/01/23 URL ct.moreover.com/?a=49788042090&p=1gw&v=1&x=B8SukRCNzpkV0usfdi6aaA Persons Michael Donovan Title PreciseDx Announces Publication in Breast Cancer Research; Validates Its AI-Enabled Platform that Predicts Early-Stage Breast Cancer Recurrence Better than Current Industry Standard Media name/outlet Le Lezard.com Country/Territory Canada Date 19/01/23 URL ct.moreover.com/?a=49787374663&p=1gw&v=1&x=d3O7nutGm96K5aVirkkYow Persons Michael Donovan Title PreciseDx Announces Publication in Breast Cancer Research; Validates Its AI-Enabled Platform that Predicts Early-Stage Breast Cancer Recurrence Better than Current Industry Standard Media name/outlet Yahoo! News Country/Territory United States Date 19/01/23 URL ct.moreover.com/?a=49787387437&p=1gw&v=1&x=uv6AdOhpMlS_mOctRztAWg Persons Michael Donovan Title PreciseDx Announces Publication in Breast Cancer Research; Validates Its AI-Enabled Platform that Predicts Early-Stage Breast Cancer Recurrence Better than Current Industry Standard Media name/outlet Yahoo! Finance Country/Territory United States Date 19/01/23 URL ct.moreover.com/?a=49787461192&p=1gw&v=1&x=i-aSpOzYlc00G3dNt7ak8A Persons Michael Donovan Title PreciseDx Announces Publication in Breast Cancer Research; Validates Its AI-Enabled Platform that Predicts.. Media name/outlet ADVFN UK Country/Territory United Kingdom Date 19/01/23 URL ct.moreover.com/?a=49787361919&p=1gw&v=1&x=tkngmf9-nYZ6fKIyGx_ULA Persons Michael Donovan Title PreciseDx Announces Publication in Breast Cancer Research; Validates Its AI-Enabled Platform that Predicts Early-Stage Breast Cancer Recurrence Better than Current Industry Standard Media name/outlet TickerTech.com Country/Territory United States Date 19/01/23 URL ct.moreover.com/?a=49787371890&p=1gw&v=1&x=nM8QeYcj83FxVuG4tHwcIg Persons Michael Donovan Title PreciseDx Announces Publication in Breast Cancer Research; Validates Its AI-Enabled Platform that Predicts Early-Stage Breast Cancer Recurrence Better than Current Industry Standard Media name/outlet ADVFN US Country/Territory United States Date 19/01/23 URL ct.moreover.com/?a=49787373395&p=1gw&v=1&x=XqYNOcaSw01p1UtwsZ38Cw Persons Michael Donovan Title PreciseDx Announces Publication in Breast Cancer Research; Validates Its AI-Enabled Platform that Predicts Early-Stage Breast Cancer Recurrence Better than Current Industry Standard Media name/outlet TD Ameritrade Country/Territory United States Date 19/01/23 URL ct.moreover.com/?a=49787382137&p=1gw&v=1&x=HhRJ4iQhL1FL0YRxMVptgw Persons Michael Donovan Title PreciseDx Announces Publication in Breast Cancer Research; Validates Its AI-Enabled Platform that Predicts Early-Stage Breast Cancer Recurrence Better than Current Industry Standard Media name/outlet APNews.com Country/Territory United States Date 19/01/23 URL ct.moreover.com/?a=49787563815&p=1gw&v=1&x=SHGoJzIXk2M-ve-zgE_umw Persons Michael Donovan Title PreciseDx Announces Publication in Breast Cancer Research; Validates Its AI-Enabled Platform that Predicts Early-Stage Breast Cancer Recurrence Better than Current Industry Standard Media name/outlet Upper Michigans Source Country/Territory United States Date 19/01/23 URL ct.moreover.com/?a=49787399435&p=1gw&v=1&x=Ej9AivcqA7l4PT1lvi-nHA Persons Michael Donovan Title PreciseDx Announces Publication in Breast Cancer Research; Validates Its AI-Enabled Platform that Predicts Early-Stage Breast Cancer Recurrence Better than Current Industry Standard Media name/outlet WVLT Country/Territory United States Date 19/01/23 URL ct.moreover.com/?a=49787420329&p=1gw&v=1&x=NPTbra-6ppWoKreeQ0yKGA Persons Michael Donovan Title PreciseDx Announces Publication in Breast Cancer Research; Validates Its AI-Enabled Platform that Predicts Early-Stage Breast Cancer Recurrence Better than Current Industry Standard Media name/outlet KCBD Country/Territory United States Date 19/01/23 URL ct.moreover.com/?a=49787422630&p=1gw&v=1&x=u84SGjdEmibJGOo4tS3_sQ Persons Michael Donovan Title PreciseDx Announces Publication in Breast Cancer Research; Validates Its AI-Enabled Platform that Predicts Early-Stage Breast Cancer Recurrence Better than Current Industry Standard Media name/outlet KYTV Country/Territory United States Date 19/01/23 URL ct.moreover.com/?a=49787423286&p=1gw&v=1&x=KeU2fBfTzTE5SY0QDyZZ6Q Persons Michael Donovan Title PreciseDx Announces Publication in Breast Cancer Research; Validates Its AI-Enabled Platform that Predicts Early-Stage Breast Cancer Recurrence Better than Current Industry Standard Media name/outlet WLOX Country/Territory United States Date 19/01/23 URL ct.moreover.com/?a=49787423364&p=1gw&v=1&x=fmeG2QEYrM2VgdAg12a1OQ Persons Michael Donovan Title PreciseDx Announces Publication in Breast Cancer Research; Validates Its AI-Enabled Platform that Predicts Early-Stage Breast Cancer Recurrence Better than Current Industry Standard Media name/outlet Hawaii News Now Country/Territory United States Date 19/01/23 URL ct.moreover.com/?a=49787423729&p=1gw&v=1&x=a4qis1oCENep4Kv1ZuDi-w Persons Michael Donovan Title PreciseDx Announces Publication in Breast Cancer Research; Validates Its AI-Enabled Platform that Predicts Early-Stage Breast Cancer Recurrence Better than Current Industry Standard Media name/outlet Wave 3 Country/Territory United States Date 19/01/23 URL ct.moreover.com/?a=49787425611&p=1gw&v=1&x=SRPBWe6M4YvP9cIjkosFEQ Persons Michael Donovan Title PreciseDx Announces Publication in Breast Cancer Research; Validates Its AI-Enabled Platform that Predicts Early-Stage Breast Cancer Recurrence Better than Current Industry Standard Media name/outlet KBTX.com Country/Territory United States Date 19/01/23 URL ct.moreover.com/?a=49787432465&p=1gw&v=1&x=qVGYFiawlz5Ekqb4eBc5sg Persons Michael Donovan Title PreciseDx Announces Publication in Breast Cancer Research; Validates Its AI-Enabled Platform that Predicts Early-Stage Breast Cancer Recurrence Better than Current Industry Standard Media name/outlet WALB 10 Country/Territory Georgia Date 19/01/23 URL ct.moreover.com/?a=49787434935&p=1gw&v=1&x=yJISXRyj3wXisAJL3gu5eA Persons Michael Donovan Title PreciseDx Announces Publication in Breast Cancer Research; Validates Its AI-Enabled Platform that Predicts Early-Stage Breast Cancer Recurrence Better than Current Industry Standard Media name/outlet NewsChannel 10 Country/Territory United States Date 19/01/23 URL ct.moreover.com/?a=49787439323&p=1gw&v=1&x=_pXTAr4CvhjozLTT0pauew Persons Michael Donovan Title PreciseDx Announces Publication in Breast Cancer Research; Validates Its AI-Enabled Platform that Predicts Early-Stage Breast Cancer Recurrence Better than Current Industry Standard Media name/outlet WSFA Country/Territory United States Date 19/01/23 URL ct.moreover.com/?a=49787439398&p=1gw&v=1&x=GM10TKmMP1ztkDmKQqzqfg Persons Michael Donovan Title PreciseDx Announces Publication in Breast Cancer Research; Validates Its AI-Enabled Platform that Predicts Early-Stage Breast Cancer Recurrence Better than Current Industry Standard Media name/outlet Fox 19 Country/Territory United States Date 19/01/23 URL ct.moreover.com/?a=49787439902&p=1gw&v=1&x=00Q5NlG9iitpvzoy_WFLVg Persons Michael Donovan Title PreciseDx Announces Publication in Breast Cancer Research; Validates Its AI-Enabled Platform that Predicts Early-Stage Breast Cancer Recurrence Better than Current Industry Standard Media name/outlet KWQC Country/Territory United States Date 19/01/23 URL ct.moreover.com/?a=49787441274&p=1gw&v=1&x=lr3I5XZAtIkUcdSdUH1Lbw Persons Michael Donovan Title PreciseDx Announces Publication in Breast Cancer Research; Validates Its AI-Enabled Platform that Predicts Early-Stage Breast Cancer Recurrence Better than Current Industry Standard Media name/outlet KWTX Country/Territory United States Date 19/01/23 URL ct.moreover.com/?a=49787445566&p=1gw&v=1&x=zD_O14HINFWp--ifDJ0-Mg Persons Michael Donovan Title PreciseDx Announces Publication in Breast Cancer Research; Validates Its AI-Enabled Platform that Predicts Early-Stage Breast Cancer Recurrence Better than Current Industry Standard Media name/outlet WKYT Country/Territory United States Date 19/01/23 URL ct.moreover.com/?a=49787448503&p=1gw&v=1&x=Ok8RRcFxvroyR-pFH6WI8Q Persons Michael Donovan Title PreciseDx Announces Publication in Breast Cancer Research; Validates Its AI-Enabled Platform that Predicts Early-Stage Breast Cancer Recurrence Better than Current Industry Standard Media name/outlet WSAZ Country/Territory United States Date 19/01/23 URL ct.moreover.com/?a=49787452338&p=1gw&v=1&x=kxrmScMxFkfIOm8p2vIP8Q Persons Michael Donovan Title PreciseDx Announces Publication in Breast Cancer Research; Validates Its AI-Enabled Platform that Predicts Early-Stage Breast Cancer Recurrence Better than Current Industry Standard Media name/outlet KKTV.com Country/Territory United States Date 19/01/23 URL ct.moreover.com/?a=49787452889&p=1gw&v=1&x=zdUcfsYgOB4xOB-yBd7Qiw Persons Michael Donovan Title PreciseDx Announces Publication in Breast Cancer Research; Validates Its AI-Enabled Platform that Predicts Early-Stage Breast Cancer Recurrence Better than Current Industry Standard Media name/outlet WBKO Country/Territory United States Date 19/01/23 URL ct.moreover.com/?a=49787453330&p=1gw&v=1&x=QjWsgFv25FyV3oYdMa5ggA Persons Michael Donovan Title PreciseDx Announces Publication in Breast Cancer Research; Validates Its AI-Enabled Platform that Predicts Early-Stage Breast Cancer Recurrence Better than Current Industry Standard Media name/outlet KOLO TV Reno Country/Territory United States Date 19/01/23 URL ct.moreover.com/?a=49787462442&p=1gw&v=1&x=PhRmBkKJVEJ3prkqkxeCbg Persons Michael Donovan Title PreciseDx Announces Publication in Breast Cancer Research; Validates Its AI-Enabled Platform that Predicts Early-Stage Breast Cancer Recurrence Better than Current Industry Standard Media name/outlet NBC12 Online Country/Territory United States Date 19/01/23 URL ct.moreover.com/?a=49787470740&p=1gw&v=1&x=22_kRpQCwTaGhJwb1kO8KA Persons Michael Donovan Title PreciseDx Announces Publication in Breast Cancer Research; Validates Its AI-Enabled Platform that Predicts Early-Stage Breast Cancer Recurrence Better than Current Industry Standard Media name/outlet WBAY Green Bay Country/Territory United States Date 19/01/23 URL ct.moreover.com/?a=49787470879&p=1gw&v=1&x=iQH-dvXsL92evoN_2npirQ Persons Michael Donovan Title PreciseDx Announces Publication in Breast Cancer Research; Validates Its AI-Enabled Platform that Predicts Early-Stage Breast Cancer Recurrence Better than Current Industry Standard Media name/outlet NBCNebraskaScottsbluff.com Country/Territory United States Date 19/01/23 URL ct.moreover.com/?a=49787470976&p=1gw&v=1&x=y4P80w0jZrHigYXDbQzQQw Persons Michael Donovan Title PreciseDx Announces Publication in Breast Cancer Research; Validates Its AI-Enabled Platform that Predicts Early-Stage Breast Cancer Recurrence Better than Current Industry Standard Media name/outlet KCRG.com Country/Territory United States Date 19/01/23 URL ct.moreover.com/?a=49787472058&p=1gw&v=1&x=O3sCRyfQZyhwiWxwTOnktA Persons Michael Donovan Title PreciseDx Announces Publication in Breast Cancer Research; Validates Its AI-Enabled Platform that Predicts Early-Stage Breast Cancer Recurrence Better than Current Industry Standard Media name/outlet WBRC Country/Territory United States Date 19/01/23 URL ct.moreover.com/?a=49787474654&p=1gw&v=1&x=EUHXGVQDutnBE30YxhekdA Persons Michael Donovan Title PreciseDx Announces Publication in Breast Cancer Research; Validates Its AI-Enabled Platform that Predicts Early-Stage Breast Cancer Recurrence Better than Current Industry Standard Media name/outlet CW39 NewsFix Country/Territory United States Date 19/01/23 URL ct.moreover.com/?a=49787497197&p=1gw&v=1&x=bySn4Hl6akE9v1MRKd9WEw Persons Michael Donovan Title PreciseDx Announces Publication in Breast Cancer Research; Validates Its AI-Enabled Platform that Predicts Early-Stage Breast Cancer Recurrence Better than Current Industry Standard Media name/outlet WTWO Country/Territory United States Date 19/01/23 URL ct.moreover.com/?a=49787498091&p=1gw&v=1&x=7yNq9Bc7Q1f0jcUOtyJqKQ Persons Michael Donovan Title PreciseDx Announces Publication in Breast Cancer Research; Validates Its AI-Enabled Platform that Predicts Early-Stage Breast Cancer Recurrence Better than Current Industry Standard Media name/outlet KOIN Country/Territory United States Date 19/01/23 URL ct.moreover.com/?a=49787509112&p=1gw&v=1&x=kblUf6CmZrW65qpl42puSw Persons Michael Donovan Title PreciseDx Announces Publication in Breast Cancer Research; Validates Its AI-Enabled Platform that Predicts Early-Stage Breast Cancer Recurrence Better than Current Industry Standard Media name/outlet Everything Lubbock Country/Territory United States Date 19/01/23 URL ct.moreover.com/?a=49787519287&p=1gw&v=1&x=eNv8erYopZgCHS9OTUfZsQ Persons Michael Donovan Title PreciseDx Announces Publication in Breast Cancer Research; Validates Its AI-Enabled Platform that Predicts Early-Stage Breast Cancer Recurrence Better than Current Industry Standard Media name/outlet WTen.com Country/Territory United States Date 19/01/23 URL ct.moreover.com/?a=49787523188&p=1gw&v=1&x=GNjNBvdsXeC2WQaN9f9zSw Persons Michael Donovan Title PreciseDx Announces Publication in Breast Cancer Research; Validates Its AI-Enabled Platform that Predicts Early-Stage Breast Cancer Recurrence Better than Current Industry Standard Media name/outlet Fox 16 Country/Territory United States Date 19/01/23 URL ct.moreover.com/?a=49787523535&p=1gw&v=1&x=hcxfGrqjWn_iWbdtgWmKbA Persons Michael Donovan Title PreciseDx Announces Publication in Breast Cancer Research; Validates Its AI-Enabled Platform that Predicts Early-Stage Breast Cancer Recurrence Better than Current Industry Standard Media name/outlet WJHL.com Country/Territory United States Date 19/01/23 URL ct.moreover.com/?a=49787524409&p=1gw&v=1&x=s8jWEIL1xX_hh2Rj_a22iw Persons Michael Donovan Title PreciseDx Announces Publication in Breast Cancer Research; Validates Its AI-Enabled Platform that Predicts Early-Stage Breast Cancer Recurrence Better than Current Industry Standard Media name/outlet NBC4 Columbus Country/Territory United States Date 19/01/23 URL ct.moreover.com/?a=49787524950&p=1gw&v=1&x=4AXhCeOpujlkggPAi_9o4g Persons Michael Donovan Title PreciseDx Announces Publication in Breast Cancer Research; Validates Its AI-Enabled Platform that Predicts Early-Stage Breast Cancer Recurrence Better than Current Industry Standard Media name/outlet YOUR BASIN Country/Territory United States Date 19/01/23 URL ct.moreover.com/?a=49787583140&p=1gw&v=1&x=RbKiezn_5K2Sw1TteOcRgQ Persons Michael Donovan Title PreciseDx Announces Publication in Breast Cancer Research; Validates Its AI-Enabled Platform that Predicts Early-Stage Breast Cancer Recurrence Better than Current Industry Standard Media name/outlet WANE-TV Country/Territory United States Date 19/01/23 URL ct.moreover.com/?a=49787610946&p=1gw&v=1&x=Z3qQesNAi_nfRWlmiMMWoA Persons Michael Donovan Title PreciseDx Announces Publication in Breast Cancer Research; Validates Its AI-Enabled Platform that Predicts Early-Stage Breast Cancer Recurrence Better than Current Industry Standard Media name/outlet MyPanhandle.com Country/Territory United States Date 19/01/23 URL ct.moreover.com/?a=49787616555&p=1gw&v=1&x=n6sykYXkc1uRUlGxylzCmw Persons Michael Donovan Title PreciseDx Announces Publication in Breast Cancer Research; Validates Its AI-Enabled Platform that Predicts Early-Stage Breast Cancer Recurrence Better than Current Industry Standard Media name/outlet Siouxland Matters Country/Territory United States Date 19/01/23 URL ct.moreover.com/?a=49787616558&p=1gw&v=1&x=I4dkFZreUz5QNPIy5ixUhg Persons Michael Donovan Title PreciseDx Announces Publication in Breast Cancer Research; Validates Its AI-Enabled Platform that Predicts Early-Stage Breast Cancer Recurrence Better than Current Industry Standard Media name/outlet WIVB Country/Territory United States Date 19/01/23 URL ct.moreover.com/?a=49787621044&p=1gw&v=1&x=D-TMSFYGIN0UvSTchgIrPQ Persons Michael Donovan Title PreciseDx Announces Publication in Breast Cancer Research; Validates Its AI-Enabled Platform that Predicts... Media name/outlet User Walls Country/Territory United States Date 19/01/23 URL ct.moreover.com/?a=49787405260&p=1gw&v=1&x=AHc5QxDbcMMvk7zpG-wBZg Persons Michael Donovan